| Biological Information | |
|---|---|
| Background Information: | Glucagon-like peptide-2 (GLP II) is a 33 amino acid GI peptide produced upon nutrient consumption via post-translational cleavage of proglucagon in intestinal endocrine cells. It has potent intestinotrophic endocrine/paracrine actions, including intestinal mucosal growth, enhanced brush-border enzyme activity, and delayed gastric transit. May be a potential therapeutic target for subjects with intestinal disease. Acts as an agonist for GLP2R. Provided as 500μg of dry powder alongside reconstitution buffer. |
| Target Name: | GLP II |
| Usage | |
| Product Type: | Peptides |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Clinical Relevance | |
| Therapeutic Area: | Metabolic Diseases |
| Additional Information | |
| Brand: | DiscoverX |
Glucagon-like Peptide 2 (GLP-2)
GLP II (1-33) (Glucagon-like peptide) is an agonist for GLP2R. This product is provided as 500μg of dry powder alongside reconstitution buffer.
Datasheets
92-1079 Datasheet
View Document